AHPA on USP ingredient information
This article was originally published in The Tan Sheet
The American Herbal Products Association asks U.S. Pharmacopoeia to "refrain from requiring cautionary statements" on "USP-quality black cohosh and USP powdered decaffeinated green tea extract" in its newly adopted ingredient safety classification system. Instead, AHPA suggests USP use a safety information section in supplement ingredient monographs to present findings from DSI-EC. This would allow manufacturers "to intelligently apply the findings of the DSI-EC as is appropriate on a product-by-product basis," the group says. The current system adopted by USP classifies ingredients into three categories: Class 1, (safe with no labeling statement), Class 2 (safe with suitable labeling statement) and Class 3 (not safe)...
You may also be interested in...
The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.
Stada has named Yann Brun to become the group’s new head of global development, portfolio, regulatory and business development, replacing Robert Knerr. The move is the latest in a string of key appointments at Stada as the firm builds on a series of acquisitions and deals.
A letter from more than 60 leading public health and medical ethics experts has been sent to Pfizer's CEO Albert Bourla.